Allosteric control of type I-A CRISPR-Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Type I CRISPR-Cas systems typically rely on a two-step process to degrade DNA. An RNA-guided complex named Cascade first identifies the complementary DNA target. The nuclease-helicase fusion enzyme Cas3 is then recruited in trans for processive DNA degradation. Contrary to this model, here we show that Type I-A Cascade and Cas3 functions as an integral effector complex. We provide four cryo-EM snapshots of the Pyrococcus furiosus Type I-A effector complex in different stages of DNA recognition and degradation. The HD nuclease of Cas3 is autoinhibited inside the effector complex. It is only allosterically activated upon full R-loop formation, when the entire targeted region has been validated by the RNA guide. The mechanistic insights inspired us to convert Pfu Cascade-Cas3 into a high-sensitivity, low-background, and temperature-activated nucleic acid detection tool. Moreover, Pfu CRISPR-Cas3 shows robust bi-directional deletion-editing activity in human cells, which could find usage in allele-specific inactivation of disease-causing mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Goddard, T. D., Huang, C. C., Meng, E. C., Pettersen, E. F., Couch, G. S., Morris, J. H., & Ferrin, T. E. (2018) · Protein Science · doi:10.1002/pro.3235 · Cited by 5,267
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
A new bioinformatics analysis tools framework at EMBL-EBI
Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., & Lopez, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq313 · Cited by 1,846
Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199
Cited by
Molecular mechanism of plasmid elimination by the DdmDE defense system
(2024) · doi:10.1126/science.adq0534 · Cited by 38
RNA targeting and cleavage by the type III-Dv CRISPR effector complex
Schwartz, E. A., Bravo, J. P. K., Ahsan, M., Macias, L. A., McCafferty, C. L., Dangerfield, T. L., Walker, J. N., Brodbelt, J. S., Palermo, G., Fineran, P. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47506-y · Cited by 30
Repurposing Type I-A CRISPR-Cas3 for a robust diagnosis of human papillomavirus (HPV)
Hu, T., Ji, Q., Ke, X., Zhou, H., Zhang, S., Ma, S., Yu, C., Ju, W., Lu, M., Lin, Y., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06537-3 · Cited by 24
Self-citationHu, C., Myers, M. T., Zhou, X., Hou, Z., Lozen, M. L., Nam, K. H., Zhang, Y., & Ke, A. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.034 · Cited by 24
Self-citationStructure and mechanism of the type I-G CRISPR effector
Shangguan, Q., Graham, S., Sundaramoorthy, R., & White, M. F. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac925 · Cited by 24
Metadata
- Authors
- Hu, C., Ni, D., Nam, K. H., Majumdar, S., McLean, J., Stahlberg, H., Terns, M. P., & Ke, A.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 82
- Issue
- 15
- Pages
- 2754-2768.e5
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W4285097940
- Cited by
- 72
- References
- 5
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.